l-carnitine in management of valproic acid induced hyperammonemia Acid-Induced Hyperammonemic Encephalopathy a Patient with Bipolar Disorder: A Case Report Valproic acid-induced hyperammonemic encephalopathy |
Description
Mendelian randomizationa journey from obscurity to center stage with a few potholes along the way
10.3233/BPL-150017 115 SleimanS
Personalizar su experiencia en base con su navegacin
The initial dose is generally administered once daily, with the tablet placed under the tongue where it rapidly dissolves without the need for water
AIDS 1997 Jan
